Trial Profile
Pharmacokinetic (PK) Study of ASP015K -Evaluation of Pharmacokinetics in Patients With Impaired Renal Function and Subjects With Normal Renal Function-
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Astellas Pharma
- 15 Nov 2019 Results comparing the pharmacokinetics and safety of a single oral dose of pefcitinib in subjects with and without impaired renal functionpublished in the Clinical Drug Investigation
- 15 Jun 2019 Results assessing exposure after a single 150 mg oral dose of peficitinib under fasting conditions between subjects with and without renal impairment presented at the 20th Annual Congress of the European League Against Rheumatism.
- 03 Jan 2017 Status changed from recruiting to completed.